Rahul Gupta, N Director, Office of National Drug Control Policy, disclosed 5 transactions | KeyVex Disclosures

KeyVex › Disclosures › Executive-branch trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Rahul Gupta, N Director, Office of National Drug Control Policy, disclosed 5 transactions

2024-03-01 · Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2024-02-15 · purchase	Kimberly-Clark Corp. — $1,001 - $15,000
2024-02-02 · purchase	3M Co. — $1,001 - $15,000
2024-01-30 · purchase	Tesla, Inc. — $1,001 - $15,000
2024-01-26 · purchase	3M Co. — $1,001 - $15,000
2024-01-26 · purchase	Kimberly-Clark Corp. — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

owner	self
source	OGE_278T
notified	false
amount max	15000
amount min	1001
filer name	Rahul Gupta
filer type	appointee
report url	https://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/63238F1EEC7732AC85258AE8002EFD09/$FILE/Rahul-Gupta-03.01.2024-278T.pdf
scraped at	2026-06-02T23:33:32.907Z
filing date	2024-03-01
amount range	$1,001 - $15,000
filer position	N Director, Office of National Drug Control Policy
transaction type	purchase

Each transaction (5)

ticker	filing id	asset name	transaction date
KMB	oge-278t-rahul-gupta-2024-03-01-5	Kimberly-Clark Corp.	2024-02-15
MMM	oge-278t-rahul-gupta-2024-03-01-4	3M Co.	2024-02-02
TSLA	oge-278t-rahul-gupta-2024-03-01-3	Tesla, Inc.	2024-01-30
MMM	oge-278t-rahul-gupta-2024-03-01-2	3M Co.	2024-01-26
KMB	oge-278t-rahul-gupta-2024-03-01-1	Kimberly-Clark Corp.	2024-01-26

Original filing document